Non-small cell lung cancer

Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
Giovanni Fucà, Giulia Galli, Marta Poggi, Giuseppe Lo Russo, Claudia Proto, Martina Imbimbo, Roberto Ferrara, Nicoletta Zilembo, Monica Ganzinelli, Antonio Sica, Valter Torri, Mario Paolo Colombo, Claudio Vernieri, Andrea Balsari, Filippo de Braud, Marina Chiara Garassino, Diego Signorelli

ESMO Open Feb 2019, 4 (1) e000457; DOI: 10.1136/esmoopen-2018-000457
Evaluation of time to failure of strategy as an alternative surrogate endpoint in patients with lung cancer with EGFR mutations
Yuki Shinno, Yasushi Goto, Sho Watanabe, Jun Sato, Ryo Morita, Yuji Matsumoto, Shuji Murakami, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe

ESMO Open Nov 2018, 3 (7) e000399; DOI: 10.1136/esmoopen-2018-000399
CSF-1 and Ang-2 serum levels — prognostic and diagnostic partners in non-small cell lung cancer
Ana Luísa Coelho, Mónica Patrícia Gomes, Raquel Jorge Catarino, Christian Rolfo, Rui Manuel Medeiros, António Manuel Araújo

ESMO Open Jul 2018, 3 (5) e000349; DOI: 10.1136/esmoopen-2018-000349
Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
Joseph A Pinto, Carlos S Vallejos, Luis E Raez, Luis A Mas, Rossana Ruiz, Junior S Torres-Roman, Zaida Morante, Jhajaira M Araujo, Henry L Gómez, Alfredo Aguilar, Denisse Bretel, Claudio J Flores, Christian Rolfo

ESMO Open Apr 2018, 3 (3) e000344; DOI: 10.1136/esmoopen-2018-000344
Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Satoshi Watanabe, Kazuhiko Ito, Akihiko Gemma, Yoshiki Demura, Shinichi Fukumoto, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Keisuke Aiba, Toshihiro Nukiwa

ESMO Open Feb 2018, 3 (2) e000313; DOI: 10.1136/esmoopen-2017-000313
Pembrolizumab as second-line therapy in non-small cell lung cancer in northern Norway: budget impact and expected gain—a model-based analysis
Jan Norum, Margareth Aarag Antonsen, Terje Tollåli, Khalid Al-Shibli, Gry Andersen, Kristin Helene Svanqvist, Nina Helbekkmo

ESMO Open Jul 2017, 2 (3) e000222; DOI: 10.1136/esmoopen-2017-000222
Immune checkpoint inhibitors for advanced non-small cell lung cancer: emerging sequencing for new treatment targets
Pedro Nazareth Aguiar, Ramon Andrade De Mello, Carmelia Maria Noia Barreto, Luke Alastair Perry, Jahan Penny-Dimri, Hakaru Tadokoro, Gilberto de Lima Lopes

ESMO Open Jul 2017, 2 (3) e000200; DOI: 10.1136/esmoopen-2017-000200
External quality assessment for EGFR mutations in Italy: improvements in performances over the time
Nicola Normanno, Francesca Fenizia, Francesca Castiglione, Massimo Barberis, Gian Luigi Taddei, Mauro Truini, Gaetano De Rosa, Carmine Pinto, Antonio Marchetti

ESMO Open May 2017, 2 (2) e000160; DOI: 10.1136/esmoopen-2017-000160
Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer
Birgit Gaschler-Markefski, Patricia Sikken, John V Heymach, Maya Gottfried, Anders Mellemgaard, Silvia Novello, Claudia-Nanette Gann, José Barrueco, Martin Reck, Nasser H Hanna, Rolf Kaiser

ESMO Open Apr 2017, 2 (1) e000102; DOI: 10.1136/esmoopen-2016-000102
Multicentre phase II study of nivolumab in Japanese patients with advanced or recurrent non-squamous non-small cell lung cancer
Makoto Nishio, Toyoaki Hida, Shinji Atagi, Hiroshi Sakai, Kazuhiko Nakagawa, Toshiaki Takahashi, Naoyuki Nogami, Hideo Saka, Mitsuhiro Takenoyama, Makoto Maemondo, Yuichiro Ohe, Hiroshi Nokihara, Tomonori Hirashima, Hiroshi Tanaka, Shiro Fujita, Koji Takeda, Koichi Goto, Miyako Satouchi, Hiroshi Isobe, Koichi Minato, Naoki Sumiyoshi, Tomohide Tamura

ESMO Open Mar 2017, 2 (Suppl 1) e000108; DOI: 10.1136/esmoopen-2016-000108

Main menu

Non-small cell lung cancer

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Non-small cell lung cancer

Pages